Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Retained Earnings (2016 - 2025)

INVO Fertility (IVF) has disclosed Retained Earnings for 15 consecutive years, with -$93.1 million as the latest value for Q3 2025.

  • Quarterly Retained Earnings fell 46.61% to -$93.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$93.1 million through Sep 2025, down 46.61% year-over-year, with the annual reading at -$67.2 million for FY2024, 16.17% down from the prior year.
  • Retained Earnings for Q3 2025 was -$93.1 million at INVO Fertility, down from -$90.2 million in the prior quarter.
  • The five-year high for Retained Earnings was -$34.7 million in Q1 2021, with the low at -$93.1 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$56.4 million, with a median of -$54.6 million recorded in 2023.
  • The sharpest move saw Retained Earnings decreased 13.37% in 2024, then plummeted 46.61% in 2025.
  • Over 5 years, Retained Earnings stood at -$38.9 million in 2021, then dropped by 28.01% to -$49.8 million in 2022, then fell by 16.14% to -$57.8 million in 2023, then dropped by 16.17% to -$67.2 million in 2024, then tumbled by 38.61% to -$93.1 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$93.1 million, -$90.2 million, and -$84.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.